Position in VRTX
as of Mar 31, 2026
· filed Apr 22, 2026
Position Value
$850,658
-$35,660 QoQ
Shares Held
1,905
-2.6% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2021
21 quarters on record
Common Shares in VRTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Spire Wealth Management holds $3,225,256 across 33 Biotechnology names. VRTX ranks #1 (26.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
This page
|
1,905 | $850,658 | |
| 2 | HALO |
Halozyme Therapeutics, Inc.
|
7,391 | $477,680 | |
| 3 | EXEL |
Exelixis, Inc.
|
10,633 | $456,049 | |
| 4 | INCY |
Incyte Corp
|
3,487 | $328,195 | |
| 5 | SRRK |
Scholar Rock Holding Corp
|
6,303 | $309,855 | |
| 6 | INSM |
INSMED Inc
|
765 | $125,092 | |
| 7 | PVLA |
Palvella Therapeutics, Inc.
|
1,000 | $124,650 | |
| 8 | NTLA |
Intellia Therapeutics, Inc.
|
9,036 | $115,841 |
All Filings in VRTX
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $850,658 | 1,905 | Shares | Sole | 2026-04-22 | |
| 2025-12-31 | $886,318 | 1,955 | Shares | Sole | 2026-01-14 | |
| 2025-09-30 | $914,871 | 2,336 | Shares | Sole | 2025-10-23 | |
| 2025-06-30 | $5,029,868 | 11,298 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $9,006,016 | 18,576 | Shares | Sole | 2025-04-23 | |
| 2024-12-31 | $7,451,560 | 18,504 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $8,707,692 | 18,723 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $9,259,094 | 19,754 | Shares | Sole | 2024-07-31 | |
| 2024-03-31 | $8,383,190 | 20,055 | Shares | Sole | 2024-04-24 | |
| 2023-12-31 | $8,402,685 | 20,651 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $5,694,937 | 16,377 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $8,154,810 | 23,173 | Shares | Sole | 2023-08-09 | |
| 2023-03-31 | $7,802,392 | 24,764 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $6,093,257 | 21,100 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $6,305,022 | 21,776 | Shares | Sole | 2022-11-07 | |
| 2022-06-30 | $7,622,983 | 27,052 | Shares | Sole | 2022-07-22 | |
| 2022-03-31 | $9,932,257 | 38,059 | Shares | Sole | 2022-04-18 | |
| 2021-12-31 | $580,402 | 2,643 | Shares | Sole | 2022-01-14 | |
| 2021-09-30 | $166,153 | 916 | Shares | Sole | 2021-10-22 | |
| 2021-06-30 | $275,426 | 1,366 | Shares | Sole | 2021-07-26 | |
| 2021-03-31 | $1,015,999 | 4,728 | Shares | Sole | 2021-05-21 | |
| No filing history on record for this holder in this stock. | ||||||